MySTYL'One
March 25, 2021
Save the date and register to our upcoming webinar!
"Design of Experiments (DoE): an essential tool to better understand tablet formulations" - by Mariana Bezerra, De Montfort University (Leicester, UK)
Registration is now open for this online event, held on April 21st, 2021
#webinar #STYLOne Nano #DOE #Design of Experiments #De Monfort University
Interesting news to share with the community?
Carried a new study out?
This newsfeed is yours, do not hesitate!
MySTYLOne
March 22, 2021
MySTYL'One user exclusive!
Head to the bulletins section to learn more on the differences between your target force and output force on your STYL’One Evo and improve your system response and be as close as possible to your target force!
Gabrielle Dupont
March 10, 2021
Help us feed the Community library, by sending us your papers, posters or news on tableting.
MEDELPHARM
March 23, 2021
Reducing “time to market” is the ultimate goal
for every pharmaceutical lab. Being the first on
the market brings a competitive advantage for
prescription, over-the-counter, or generic-drug
manufacturers. Applying quality-by-design
(QbD) principles at the formulation phase can
prevent tablet defects at an early stage and
thereby drastically reduce time during the
complex and troublesome phase of “scale-up”.
www.danone.com
March 18, 2021
Danone has announced the commercialization of milk-powder tablets in the UK thanks to a partnership with the Japanese company Meiji which owns the patent for such pre-measured tab format. Meiji’s development has been made possible thanks to the STYL’One Evo compaction simulator. Check out Danone's press release and Meiji’s technology on Danone's website.
Skyepharma
March 15, 2021
MySTYL'One users exclusive!
Flashback on Aline Moulin (Skyepharma)'s presentation at CSF Cambridge 2018.
Discover the presentation of Skyepharma's study: "Correlation between STYL’One Evolution and an industrial rotary press on a tab-in-tab dosage form" directly in our library of bulletins (access is only open to STYL'One users)
#multilayer #controlled release #industrial rotary press #compaction simulator #tab-in-tab
MySTYL'One
March 4, 2021
On February 17th, Cedrine de Backere, PhD Student
from Ghent University (Belgium) presented her work on external lubrication and
how to mitigate the impact of lubricants on quality attributes. Bruno Leclercq,
MEDELPHARM’s Science Lab Head and Business Developer also presented innovations
from MEDELPHARM
on external lubrication. The session ended with a Q&A.
For those who could not join us you can freely access the
transcript below.
Note: the registered members of MySTYL’One can access ...
On February 17th, Cedrine de Backere, PhD Student
from Ghent University (Belgium) presented her work on external lubrication and
how to mitigate the impact of lubricants on quality attributes. Bruno Leclercq,
MEDELPHARM’s Science Lab Head and Business Developer also presented innovations
from MEDELPHARM
on external lubrication. The session ended with a Q&A.
For those who could not join us you can freely access the
transcript below.
Note: the registered members of MySTYL’One can access the full video of the webinar HERE.
www.pharmaphorum.com
March 3, 2021
UCB's announced a new partnership in order to integrate IA technologies as a tool for its development.The aim is to "significantly accelerate the iteration cycles required to identify more effective molecules".
The complete Press article can be found here.
www.cphi-online.com
Feb. 23, 2021
This article we've spotted on CPhI's website shows that the pharma industry is changing its mindset for a new exciting leap into embracing IOT and adopting manufacturing digital innovation.
More to be read on this website.
MySTYL'One
Feb. 23, 2021
MySTYL'One users exclusive!
Flashback to STYL'One User Group 2017... but still up-to-date!
TU Braunschweig I-Pat team's transfered us their presentation on materials characterization and process modeling (Heckel, Cooper and Eaton...).
Food for thought, and reactions welcome on the Forum!
Read the document here. (MySTYL'One users exclusive)